CTXR — Citius Pharmaceuticals Share News
0.000.00%
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules
Brief: Citius Oncology Expands Lymphir Distribution To Turkey And Middle East Countries
Brief: Citius Pharmaceuticals Announces The Closing Of Registered Direct Offering Of $6.0 Million Priced At-The-Market Under Nasdaq Rules
Brief: Citius Pharmaceuticals Announces a Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules
Brief: Citius Oncology Signs U.S. Distribution Agreement With Mckesson To Support Lymphir Commercial Launch
Brief: Citius Oncology Signs Exclusive Commercialization Agreement With EVERSANA To Support Planned Q4 2025 Launch Of LYMPHIR
Brief: Citius Oncology Announces Closing Of $9 Million Registered Direct Offering And Concurrent Private Placement
Brief: Citius Oncology Prices $9M Direct Offering & Private Placement
Citius Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Citius Pharmaceuticals Inc expected to post a loss of 59 cents a share - Earnings Preview
Brief: Citius Oncology Announces Closing Of $9.0 Million Public Offering
Brief: Citius Pharmaceuticals Announces Closing Of Registered Direct Offering Of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules
Brief: Citius Oncology Enters Into Distribution Services Agreement With Cardinal Health
Citius Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Citius Pharmaceuticals Reports Fiscal Second Quarter 2025 Financial Results And Provides Business Update
Citius Pharmaceuticals Inc expected to post earnings of 33 cents a share - Earnings Preview